About Celerion
Celerion is a company based in Lincoln (United States) founded in 2010 was acquired by Thomas H Lee Partners in April 2026. The company has 940 employees. Celerion offers products and services including Bioanalytical Sciences, ClinQuick, and Celexus. Celerion operates in a competitive market with competitors including Altasciences, Ask Gene Pharma, Open Orphan, iCardiac Technologies and AWAKN, among others.
- Headquarter Lincoln, United States
- Employees 940
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Website celerion.com
- Social LinkedIn
- Acquired by H.I.G. Capital (Nov 2022)
- Legal Name Celerion, Inc.
- InvestorsThomas H Lee Partners
& 2 more
- Employee Count940
- Acquired by
Products & Services of Celerion
Celerion offers a comprehensive portfolio of products and services, including Bioanalytical Sciences, ClinQuick, and Celexus.
Delivers analysis of molecules for drug development phases
Platform for efficient clinical trial management
System for data handling in research studies
Investors in Celerion
Celerion has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include Thomas H Lee Partners, WindRose Health Investors and H.I.G. Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
US healthcare investments are managed by private equity firm. | – | windrose.com | New York, United States | |
Private equity investments are directed toward traditional industries. | 1974 | thl.com | Boston, United States | |
Private equity capital is invested in small and mid-sized businesses. | – | higcapital.com | Miami, United States |
Investor details for Celerion
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Celerion
208 people are tracked at Celerion (61 in leadership, 147 in team); the tracked headcount is 940.
| Name | Role | Group |
|---|---|---|
Susan Thornton | Chief Executive Officer | Leadership |
JoAnne Rosal | Chief Financial Officer | Leadership |
J. Fred Pritchard | VP, Global Drug Development | Leadership |
Abbey Townsend | Senior Director, Global Clinical Development North America | Leadership |
Christine Brandquist | Associate Director Of Clinical Pharmacology | Leadership |
Kim Lapeirre | Director, Business Development | Leadership |
Julia Strong | Associate Director, Global Project Management | Leadership |
Kirk Newland | Technical Director Tobacco Research | Leadership |
Aron Robinson | Business Development Director, Bioanalytical Services | Leadership |
Ashleigh Wheeler | Associate Director, Clinical Monitoring Services, Global Clinical Development | Leadership |
Christopher Steele | Associate Director Biostatistics | Leadership |
Jessica Kopejtka | Associate Director, Bioanalytical Operations | Leadership |
Joanne Bailey | Executive Director, Global Operations, Data Management And Biometrics | Leadership |
Emanuel Owens | Director, Business Development | Leadership |
John Horkulak | Vice President Corporate Development | Leadership |
Aricia Pfaff | Executive Director Business Development | Leadership |
Summer Jensen | Senior Director, Business Development | Leadership |
Christina Smith | Director Of Business Development | Leadership |
Michelle Stache | Associate Director Proposal And Financial Management | Leadership |
Kathleen Keenan (Butehorn) | Senior Director, Proposal And Financial Management | Leadership |
188 more people are available in the full profile.
Complete people profiles for Celerion
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Celerion
4 dated milestones of Celerion across 16 years, from founding to its latest funding, stage changes and deals.
- Founded Celerion is founded.
- Exit Acquired by WindRose Health Investors.
- Exit Acquired by H.I.G. Capital.
- Exit Acquired by Thomas H Lee Partners.
Competitors of Celerion
Celerion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Altasciences, Ask Gene Pharma, Open Orphan, iCardiac Technologies and AWAKN, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| altasciences.com | 2015 | Laval, Canada | – | 249 | Early phase clinical research services are provided in North America. | |
| ask-gene.com | 2012 | Camarillo, United States | $20M | 24 | Biosimilars and biosuperiors are developed and commercialized in biotechnology. | |
| openorphan.com | 2017 | London, United Kingdom | – | 218 | Provider of testing vaccines & antivirals and CRO pharmaceutical services | |
| icardiac.com | 2006 | Rochester, United States | $4M | – | Cardiac safety testing and respiratory laboratory services are provided. | |
| awaknlifesciences.com | 2020 | Portishead, United Kingdom | – | 49 | CRO focused on early stage clinical trial research | |
| avancecro.com | 2018 | Thebarton, Australia | – | – | Clinical development services are provided to pharmaceutical clients worldwide. | |
| clerkenwellhealth.com | 2020 | London, United Kingdom | $2.33M | – | CRO focused on conducting early stage clinical development of psychedelic medicines | |
| spauldingclinical.com | 2007 | West Bend, United States | $1.71M | – | CRO services for Phase I Clinical Trials, and Core ECG lab services for trials from Phase I to IV | |
| hmrlondon.com | 1993 | London, United Kingdom | – | – | CRO which has worked in 670+ trials and specializes in early stage clinical trials |
Detailed competitors of Celerion
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Celerion
The website of Celerion (celerion.com) receives about 25.4K visits a month and ranks #1,182,554 among all websites worldwide, #1,478 in Biotechnology and Pharmaceuticals.
- Monthly visits25.4K
▲ 9.3% vs previous month
- Unique visitors9.3K
per month
- Global rank#1,182,554
among all websites
- Category rank#1,478
Health · Biotechnology and Pharmaceuticals
- Bounce rate48%
- Pages per visit2.1
- Average visit3 min 41 sec
- DevicesDesktop 22% · Mobile 78%
Websites whose visitors overlap most with Celerion. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| covance.com | 100% | 20.2K | #688,229 | View details | |
| iconplc.com | 91% | 476.9K | #92,950 | View details | |
| gctrials.com | 87% | – | #13,093,249 | View details | |
| tklresearch.com | 87% | 9.5K | #4,608,578 | View details | |
| centerwatch.com | 78% | 158.2K | #254,725 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for Celerion
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Latest news on Celerion
Complete news archive for Celerion
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Celerion
10 companies that operate in the same segment as Celerion (Biopharma Outsourcing & Drug Delivery), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Drug discovery and development services are provided to biopharma sector. | 1993 | Hamburg, Hamburg, Germany | USD 25 M | USD 926.33 M | 4,830 | |
Drug discovery and development services for small molecules are provided. | 2003 | Beijing, China | USD 320 M | – | 476 | |
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 255.15 M | USD 374.1 M | 4,490 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
Pharmaceutical products for treating multiple diseases are provided. | 1849 | New York, New York, United States | USD 8 M | USD 266.99 M | 1,770 | |
Provider of laboratory tests for physicians | 1969 | Burlington, Vermont, United States | – | USD 13.95 B | 70,000 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Celerion
Celerion was founded in 2010.
Celerion is headquartered in Lincoln, United States. It is registered at Lincoln, Nebraska, United States.
Celerion has 940 employees.
Celerion provides early clinical research services for pharmaceutical and biotechnology companies in the United States and internationally. The company focuses on delivering applied translational medicine to support early drug development decisions. Its services include global clinical research (Phase I and II, and NDA-enabling clinical pharmacology study conduct); clinical pharmacology sciences (modeling and simulation, study design and protocol development, clinical data sciences, biostatistics, pharmacokineticspharmacodynamics (PKPD), and medical writing and reporting); global bioanalytical services (discovery to late stage services with capabilities in small and large drug, and metabolite and biomarker molecules); and drug development services (program and project management, regulatory services, and drug development consultancy). The company also specializes in providing medical writing (protocols and reports), clinical data sciences, biostatistics, and PKPD analysis, as well as small and large molecule bioanalytical assays through clinical drug development. It serves its clients through its global network of owned facilities in Lincoln, Nebraska; Phoenix and Tempe, Arizona; West Conshohocken, Pennsylvania; Montreal, Canada; Belfast, Northern Ireland; and Zurich, Switzerland. The company was founded in 2010 and is based in Lincoln, Nebraska. It also has operations in Richmond, Virginia; Montreal, Canada; and South Korea. The company was formed when Bain CapitalVentures and SV Life Sciences acquired MDS Pharma Services Early Stage Business. In 2014 they divested a majority stake in the company to MTS Partners.
Celerion's top competitors include Ask Gene Pharma, HMR London and Altasciences.
Celerion offers Bioanalytical Sciences, ClinQuick, and Celexus.
Celerion has 3 investors. Key investors include Thomas H Lee Partners, WindRose Health Investors, and H.I.G. Capital.
Celerion operates through Celerion, Inc..
Yes. Celerion was acquired by H.I.G. Capital in November 2022.